Related Experiment Videos
Translocation (1;3)(p36;q21) in secondary leukemia
A D Panani1, A Ferti-Passantonopoulou, T Economopoulos
1Second Department of Internal Medicine, Propaedeutic of Athens University, Athens, Greece.
Cancer Genetics and Cytogenetics
|November 1, 1990
Summary
A rare case of acute nonlymphocytic leukemia (M4) developed after multiple myeloma treatment. This secondary leukemia showed specific genetic abnormalities, including a t(1;3) translocation and monosomy 7.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Multiple myeloma is a plasma cell malignancy.
- Treatment for multiple myeloma can include chemotherapy and other therapies.
- Secondary malignancies, including leukemia, can arise as a complication of cancer treatment.
Observation:
- A patient with multiple myeloma developed acute nonlymphocytic leukemia.
- The leukemia was classified as subtype M4.
- The patient had undergone treatment for multiple myeloma.
Findings:
- The secondary leukemia exhibited a specific chromosomal translocation: t(1;3)(p36;q21).
- Monosomy 7 was also detected in the leukemic cells.
- These genetic abnormalities are associated with myeloid leukemias.
Implications:
- This case highlights the risk of therapy-related myeloid neoplasms.
- Understanding the genetic landscape of secondary leukemia is crucial for diagnosis and prognosis.
- Further research is needed to elucidate the mechanisms linking multiple myeloma treatment to secondary leukemia development.